Daniel J. Lippis, CVP, JAPAC at Edwards Lifesciences Corp (EW), sold 3,430 shares at $90.98 ($312K) on 2024-03-07, disclosed to the SEC on 2024-03-07.
Scheduled sale ($312k) by CVP, JAPAC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.98 | 1,715 | $156K | 50.0% |
| 2 | $90.98 | 1,715 | $156K | 50.0% |
| Total | $90.98 avg | 3,430 | $312K | 100% |
| Filing → |
| EW | SELL | 2026-08-11 | $57K | — | Filing → |
| EW | SELL | 2026-07-10 | $57K | — | Filing → |
| EW | SELL | 2026-06-30 | $57K | — | Filing → |